This Week Health
Search Icon
Subscribe
Subscribe
Alex's Lemonade Stand This Week Health
February 13, 2024

23andMe’s Fall From $6 Billion to Nearly $0

WSJ
|
Summary
23andMe, once valued at $6 billion, now risks Nasdaq delisting with valuation down 98%, under $1 stock; CEO Wojcicki's billions lost; staff reduced 25% via layoffs, subsidiary sale; company unprofitable, may exhaust cash by 2025.

Explore Related Content

Recent Related Episodes

UnHack (the Podcast): Creating Security Ambassadors and AI Ethics with Chase Franzen
UnHack (the Podcast): Creating Security Ambassadors and AI Ethics with Chase Franzen
Keynote: Workforce Resilience - Burnout, Balance, and Belonging
Keynote: Workforce Resilience - Burnout, Balance, and Belonging
Townhall: Bringing Innovation to Rural Healthcare with Dr. William Morgan
Townhall: Bringing Innovation to Rural Healthcare with Dr. William Morgan
Flourish: From CIO to Solo Practice and Taking the Bold Steps with Dr. Stephanie Lahr
Flourish: From CIO to Solo Practice and Taking the Bold Steps with Dr. Stephanie Lahr

Recent Related Articles

Why Organizations Use Interim Models & How to Make Them Work
Why Organizations Use Interim Models & How to Make Them Work
Read Article
CIO Alan Smith on The Upside of Disaster and the Issue Healthcare Can No Longer Neglect
CIO Alan Smith on The Upside of Disaster and the Issue Healthcare Can No Longer Neglect
Read Article
“Fighting as Independents”: Chris Plummer On Silos, Budgets and Other Cybersecurity Hurdles
“Fighting as Independents”: Chris Plummer On Silos, Budgets and Other Cybersecurity Hurdles
Read Article
“Own Your Destiny”: Anna Schoenbaum's Blueprint For Launching - Or Advancing - a Health IT Career
“Own Your Destiny”: Anna Schoenbaum's Blueprint For Launching - Or Advancing - a Health IT Career
Read Article

Get Daily Headlines Straight to Your Inbox.

Subscribe Now
Healthcare Transformation Powered by Community

© Copyright 2024 Health Lyrics All rights reserved